Clinical Study on Combined Phacoemulsification and Intraocular Lens Implantation/Trabeculectomy with Mitomycin C.
- Author:
Kun Jin YANG
1
;
Jong Hak JEONG
Author Information
1. Department of Ophthalmology, Chonnam University Medical School, Kwangju, Korea.
- Publication Type:Original Article
- Keywords:
Mitomycin C;
Triple procedure;
Intraocular pressure control;
Complication
- MeSH:
Anterior Chamber;
Cataract;
Follow-Up Studies;
Glaucoma;
Humans;
Hyphema;
Intraocular Pressure;
Jeollanam-do;
Lenses, Intraocular*;
Macular Edema;
Mitomycin*;
Phacoemulsification*;
Postoperative Complications;
Trabeculectomy;
Visual Acuity
- From:Journal of the Korean Ophthalmological Society
1996;37(12):2065-2072
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
This study was undertaken to evaluate the outcome of combined phacoemulsification, intraocular lens implanation, and trabeculectomy with Mitomycin C. We reviewed 39 eyes in 36 consecutive cases who had been undergone triple procedure for coexisting cataract and glaucoma from January 1993 to October 1995 at Chonnam university hospital. The mean follow-up period was 8. 8 months. Preoperatively, most patients had a visual acuity of worse than 0.4, but the visual acuity improved postoperatively in 20 eyes (51.0%) achieving the visual acuity better than 0.5 at 6 months after the surgery. The mean preoperative intraocular pressure was 31.1 +/- 12.9mmHg, and the mean postoperative IOP was 16.5 +/- 5.4mmHg at 6 months follow-up. The mean number of antiglaucoma medication was 1.87 preoperatively, and 0.28 postoperatively. The postoperative complications were posterior capsular opacity (7 eyes), hyphema (2 eyes), shallow anterior chamber (3 eyes), transient hypotony without macular edema (2 eyes). There was no statistically significant difference in intraocular pressure control at different concentration of Mitomycin C (0.2 and 0.4mg/ml). We conclude that the use of Mitomycin C in combined procedure provides good short-term(6 months) results regarding intraocular pressure control and visual recovery.
